Remus Pharmaceuticals Ltd REMUS.NS

₹865.25 ₹147.00 (20.47%) 1D

Last Updated: May 15, 12:00 AM·NSE

REMUS.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: December 30, 2025

Report Source: 2026 2nd Quarter Report

Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Ltd. Stock Analysis REMUS.NS

India Health Care Micro Cap Report:
Remus Pharmaceuticals Ltd. operates as a pharmaceutical company. The firm also deals in active pharmaceutical ingredients (APIs). The company also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. The company offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. The company deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The firm offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.
Read More

Remus Pharmaceuticals Ltd (REMUS.NS) Chart

Key Statistics of Remus Pharmaceuticals Ltd (REMUS.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹718.00₹865.25

Today's Open

₹718.25

Volume

75.50K

P/E Ratio (TTM)

29.73

52 Week Range

₹580.00₹1,139.50

Market Cap

8.45B

Avg. Volume

6033.33

Dividend Yield

0.14%

Financial Metrics & Statements of Remus Pharmaceuticals Ltd (REMUS.NS)

FAQ's for Remus Pharmaceuticals Ltd (REMUS.NS)

  • According to Musaffa’s Shariah screening methodology, Remus Pharmaceuticals Ltd (REMUS.NS) is currently classified as HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.